Skip to main content Accessibility help

Pituitary volume, stress reactivity and genetic risk for psychotic disorder

  • P. Habets (a1), D. Collip (a1), I. Myin-Germeys (a1), E. Gronenschild (a1), S. van Bronswijk (a1), P. Hofman (a2), T. Lataster (a1), M. Lardinois (a1), N. A. Nicolson (a1), J. van Os (a1) (a3) and M. Marcelis (a1)...



Hypothalamic–pituitary–adrenal (HPA) axis hyperactivity, associated with increased pituitary volume, may mediate observed alterations in stress reactivity in patients with psychotic disorder. We examined the association between pituitary volume, real-life stress reactivity and genetic liability for psychotic disorder.


Pituitary volumes were derived from magnetic resonance imaging (MRI) scans of 20 patients with psychotic disorder, 37 non-psychotic siblings of these patients, and 32 controls. The Experience Sampling Method (ESM) was used to measure emotional stress reactivity [changes in negative affect (NA) associated with daily life stress] in the three groups, and biological stress reactivity (changes in cortisol associated with daily life stress) in siblings and controls. Interactions between group, stress and pituitary volume in models of NA and cortisol were examined.


Groups did not differ in pituitary volume. Patients showed significantly higher emotional stress reactivity than siblings and controls. In addition, emotional stress reactivity increased with increasing pituitary volume to a greater degree in patients than in controls and siblings. Siblings had higher cortisol levels than controls but did not show increased cortisol reactivity to stress. There was no interaction between pituitary volume, stress and group in the model of cortisol.


Higher pituitary volume was associated with increased emotional stress reactivity in patients with psychotic disorder, siblings and controls. The association was significantly stronger in the patient group, suggesting a process of progressive sensitization mediating clinical outcome.


Corresponding author

*Address for correspondence: M. Marcelis, M.D., Ph.D., Department of Psychiatry and Psychology, Maastricht University Medical Center, PO Box 616 (Vijv1), 6200 MD Maastricht, The Netherlands. (Email:


Hide All
Abech, DD, Moratelli, HB, Leite, SC, Oliveira, MC (2005). Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women. Gynecological Endocrinology 21, 223226.
Andreasen, NC, Flaum, M, Arndt, S (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.
APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision (DSM-IV-TR). American Psychiatric Association: Washington, DC.
Boerma, MA, van der Stel, JC, van Amelsvoort, T, Linszen, DH, de Haan, L (2010). Women, schizophrenia and estrogen; neurobiological hypotheses and hormone therapy studies [in Dutch]. Tijdschrift voor Psychiatrie 52, 235244.
Brenner, K, Liu, A, Laplante, DP, Lupien, S, Pruessner, JC, Ciampi, A, Joober, R, King, S (2009). Cortisol response to a psychosocial stressor in schizophrenia: blunted, delayed, or normal? Psychoneuroendocrinology 34, 859868.
Clayton, D, Hills, M (1993). Statistical Models in Epidemiology. Oxford University Press: Oxford.
Collip, D, Myin-Germeys, I, van Os, J (2008). Does the concept of ‘sensitization’ provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophrenia Bulletin 34, 220225.
Collip, D, Nicolson, NA, Lardinois, M, Lataster, T, van Os, J, Myin-Germeys, I (2011). Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychological Medicine 41, 23052315.
Crow, TJ (1980). Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280, 6668.
Csikszentmihalyi, M, Larson, R (1987). Validity and reliability of the Experience-Sampling Method. Journal of Nervous and Mental Disease 175, 526536.
Dale, AM, Fischl, B, Sereno, MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9, 179194.
Delespaul, P, deVries, M, van Os, J (2002). Determinants of occurrence and recovery from hallucinations in daily life. Social Psychiatry and Psychiatric Epidemiology 37, 97–104.
Doraiswamy, PM, Potts, JM, Axelson, DA, Husain, MM, Lurie, SN, Na, C, Escalona, PR, McDonald, WM, Figiel, GS, Ellinwood, Jr. EH (1992). MR assessment of pituitary gland morphology in healthy volunteers: age- and gender-related differences. American Journal of Neuroradiology 13, 12951299.
Fischl, B, Sereno, MI, Dale, AM (1999). Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. NeuroImage 9, 195207.
Garner, B, Pariante, CM, Wood, SJ, Velakoulis, D, Phillips, L, Soulsby, B, Brewer, WJ, Smith, DJ, Dazzan, P, Berger, GE, Yung, AR, van den Buuse, M, Murray, R, McGorry, PD, Pantelis, C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry 58, 417423.
Grams, AE, Gempt, J, Stahl, A, Forschler, A (2010). Female pituitary size in relation to age and hormonal factors. Neuroendocrinology 92, 128132.
Green, AS, Rafaeli, E, Bolger, N, Shrout, PE, Reis, HT (2006). Paper or plastic? Data equivalence in paper and electronic diaries. Psychological Methods 11, 87–105.
Gronenschild, EH, Burgmans, S, Smeets, F, Vuurman, EF, Uylings, HB, Jolles, J (2010). A time-saving and facilitating approach for segmentation of anatomically defined cortical regions: MRI volumetry. Psychiatry Research 181, 211218.
Habets, P, Marcelis, M, Gronenschild, E, Drukker, M, van Os, J (2011). Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biological Psychiatry 69, 487494.
Herz, MI, Fava, GA, Molnar, G, Edwards, L (1985). The dexamethasone suppression test in newly hospitalized schizophrenic patients. American Journal of Psychiatry 142, 127129.
Jovicich, J, Czanner, S, Han, X, Salat, D, van der Kouwe, A, Quinn, B, Pacheco, J, Albert, M, Killiany, R, Blacker, D, Maguire, P, Rosas, D, Makris, N, Gollub, R, Dale, A, Dickerson, BC, Fischl, B (2009). MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. NeuroImage 46, 177192.
Kay, SR, Fiszbein, A, Opler, LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261276.
Lammers, CH, Garcia-Borreguero, D, Schmider, J, Gotthardt, U, Dettling, M, Holsboer, F, Heuser, IJ (1995). Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biological Psychiatry 38, 803807.
Lardinois, M, Lataster, T, Mengelers, R, van Os, J, Myin-Germeys, I (2010). Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiatrica Scandinavica 123, 2835.
Lataster, T, Collip, D, Lardinois, M, van Os, J, Myin-Germeys, I (2010). Evidence for a familial correlation between increased reactivity to stress and positive psychotic symptoms. Acta Psychiatrica Scandinavica 122, 395404.
MacMaster, FP, El-Sheikh, R, Upadhyaya, AR, Nutche, J, Rosenberg, DR, Keshavan, M (2007). Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: a pilot study. Schizophrenia Research 92, 207210.
Marcelis, M, Cavalier, E, Gielen, J, Delespaul, P, van Os, J (2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization? Psychological Medicine 34, 11031111.
Mondelli, V, Dazzan, P, Gabilondo, A, Tournikioti, K, Walshe, M, Marshall, N, Schulze, KK, Murray, RM, McDonald, C, Pariante, CM (2008). Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 33, 10041012.
Mondelli, V, Dazzan, P, Hepgul, N, Di Forti, M, Aas, M, D'Albenzio, A, Di Nicola, M, Fisher, H, Handley, R, Marques, TR, Morgan, C, Navari, S, Taylor, H, Papadopoulos, A, Aitchison, KJ, Murray, RM, Pariante, CM (2010). Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research 116, 234242.
Murray, RM, O'Callaghan, E, Castle, DJ, Lewis, SW (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin 18, 319332.
Myin-Germeys, I, Delespaul, P, van Os, J (2005). Behavioural sensitization to daily life stress in psychosis. Psychological Medicine 35, 733741.
Myin-Germeys, I, Krabbendam, L, Delespaul, PA, van Os, J (2003). Do life events have their effect on psychosis by influencing the emotional reactivity to daily life stress? Psychological Medicine 33, 327333.
Myin-Germeys, I, Oorschot, M, Collip, D, Lataster, J, Delespaul, P, van Os, J (2009). Experience sampling research in psychopathology: opening the black box of daily life. Psychological Medicine 39, 15331547.
Myin-Germeys, I, van Os, J (2007). Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clinical Psychology Review 27, 409424.
Myin-Germeys, I, van Os, J, Schwartz, JE, Stone, AA, Delespaul, PA (2001). Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 58, 11371144.
Nicolo, JP, Berger, GE, Garner, BA, Velakoulis, D, Markulev, C, Kerr, M, McGorry, PD, Proffitt, TM, McConchie, M, Pantelis, C, Wood, SJ (2010). The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophrenia Research 116, 4954.
Pariante, CM (2006). The glucocorticoid receptor: part of the solution or part of the problem? Journal of Psychopharmacology 20, 7984.
Pariante, CM, Dazzan, P, Danese, A, Morgan, KD, Brudaglio, F, Morgan, C, Fearon, P, Orr, K, Hutchinson, G, Pantelis, C, Velakoulis, D, Jones, PB, Leff, J, Murray, RM (2005). Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the Æsop first-onset psychosis study. Neuropsychopharmacology 30, 19231931.
Pariante, CM, Vassilopoulou, K, Velakoulis, D, Phillips, L, Soulsby, B, Wood, SJ, Brewer, W, Smith, DJ, Dazzan, P, Yung, AR, Zervas, IM, Christodoulou, GN, Murray, R, McGorry, PD, Pantelis, C (2004). Pituitary volume in psychosis. British Journal of Psychiatry 185, 5–10.
Phillips, LJ, McGorry, PD, Garner, B, Thompson, KN, Pantelis, C, Wood, SJ, Berger, G (2006). Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Australian and New Zealand Journal of Psychiatry 40, 725741.
Robins, E, Guze, SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126, 983987.
Ryan, MC, Sharifi, N, Condren, R, Thakore, JH (2004). Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29, 10651070.
Sassi, RB, Nicoletti, M, Brambilla, P, Harenski, K, Mallinger, AG, Frank, E, Kupfer, DJ, Keshavan, MS, Soares, JC (2001). Decreased pituitary volume in patients with bipolar disorder. Biological Psychiatry 50, 271280.
StataCorp (2009). Stata Statistical Software: Release 11. StataCorp LP: College Station, TX.
Stone, AA, Shiffman, S, Schwartz, JE, Broderick, JE, Hufford, MR (2002). Patient non-compliance with paper diaries. British Medical Journal 324, 11931194.
Sulon, J, Demey-Ponsart, L, Beauduin, P, Sodoyez, JC (1978). Radioimmunoassay of corticosterone, cortisol and cortisone: their application to human cord and maternal plasma. Journal of Steroid Biochemistry 9, 671676.
Takahashi, T, Suzuki, M, Velakoulis, D, Lorenzetti, V, Soulsby, B, Zhou, SY, Nakamura, K, Seto, H, Kurachi, M, Pantelis, C (2009). Increased pituitary volume in schizophrenia spectrum disorders. Schizophrenia Research 108, 114121.
Tournikioti, K, Tansella, M, Perlini, C, Rambaldelli, G, Cerini, R, Versace, A, Andreone, N, Dusi, N, Balestrieri, M, Malago, R, Gasparini, A, Brambilla, P (2007). Normal pituitary volumes in chronic schizophrenia. Psychiatry Research 154, 4148.
Upadhyaya, AR, El-Sheikh, R, MacMaster, FP, Diwadkar, VA, Keshavan, MS (2007). Pituitary volume in neuroleptic-naive schizophrenia: a structural MRI study. Schizophrenia Research 90, 266273.
van Os, J, Gilvarry, C, Bale, R, Van Horn, E, Tattan, T, White, I, Murray, R (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine 29, 595606.
van Venrooij, JA, Fluitman, SB, Lijmer, JG, Kavelaars, A, Heijnen, CJ, Westenberg, HG, Kahn, RS, Gispen-de Wied, CC (2010). Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. Published online: 17 June 2010. doi:10.1093/schbul/sbq062.
Walker, EF, Brennan, PA, Esterberg, M, Brasfield, J, Pearce, B, Compton, MT (2010). Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. Journal of Abnormal Psychology 119, 401408.
Walker, EF, Diforio, D (1997). Schizophrenia: a neural diathesis-stress model. Psychological Review 104, 667685.
WHO (1990). Composite International Diagnostic Interview (CIDI). World Health Organization: Geneva.


Pituitary volume, stress reactivity and genetic risk for psychotic disorder

  • P. Habets (a1), D. Collip (a1), I. Myin-Germeys (a1), E. Gronenschild (a1), S. van Bronswijk (a1), P. Hofman (a2), T. Lataster (a1), M. Lardinois (a1), N. A. Nicolson (a1), J. van Os (a1) (a3) and M. Marcelis (a1)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed